Po-Cheng Liang

13PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Metabolic medicineCardiology (incl. cardiovascular diseases)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 08, 2026
The Clinical Utility of Adding Laminin Gamma 2 Monomer to the PAGE-B Score for Hepatocellular Carcinoma Surveillance in Chronic Hepatitis B.

|Aug 04, 2026
Association Between ADH1B rs1229984 Genetic Polymorphism and Hepatic Steatosis Assessed by CT Attenuation: A Mediation Analysis of Central Obesity in MASLD.

|Jul 14, 2026
Cardiometabolic Biomarkers for Disease Severity Prediction in Metabolic Dysfunction-Associated Steatotic Liver Disease.

|Apr 23, 2026
Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver-Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral Therapy.

|Dec 26, 2025
Advanced Fibrosis and Cardiometabolic Risk Burden Increase Major Cardiovascular Events in Chronic Hepatitis C Patients With Steatotic Liver Disease After Viral Eradication.

Pei-Chien Tsai, Chung-Feng Huang, Ming-Lun Yeh

|Sep 27, 2025
Phase IIb Trial for the Palliative Treatment of Patients With Primary Hepatic Malignancy Unable to Receive Curative Treatment: Efficacy of Colchicine.

Zu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang

Pageof 3

Frequent Collaborators

12 joint publications

Chung-Feng Huang

11 joint publications

Chia-Yen Dai

11 joint publications

Ming-Lung Yu

10 joint publications

Ming-Lun Yeh